AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ONCOSIL MEDICAL LTD

1.000

-0.050-4.76%

Volume:7.66K

Turnover:7.69K

Market Cap:11.52M

PE:- -

High:1.050

Open:1.050

Low:1.000

Close:1.050

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ONCOSIL MEDICAL LTD

Exchange:

ASX

Establishment Date:

2005

Employees:

- -

Office Location:

7 Eden Park Drive,Level 5,Macquarie Park,New South Wales,Australia

Website:

http://www.oncosil.com.au

Zip Code:

2113

Phone:

Fax:

- -

Introduction:

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OSLDA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSLDA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSLDA.AU\",,,,,undefined,":{"symbol":"OSLDA.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":1,"timestamp":1749190320000,"preClose":1.05,"halted":0,"volume":7662,"delay":0,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":0,"shares":11516500,"eps":0,"marketStatus":"Market Closed","change":-0.05,"latestTime":"06-06 16:12:00 AEST","open":1.05,"high":1.05,"low":1,"amount":7694,"amplitude":0.047619,"askPrice":1.09,"askSize":375,"bidPrice":1,"bidSize":10431,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"listingDate":1748786400000,"exchange":"ASX","adjPreClose":1.05,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":0.44590583301257447,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSLDA.AU\",,,,,undefined,":{"symbol":"OSLDA.AU","floatShares":0,"roa":"-87.77%","roe":"-199.38%","lyrEps":0,"volumeRatio":0.44590583301257447,"shares":11516500,"dividePrice":0,"high":1.05,"amplitude":0.047619,"preClose":1.05,"low":1,"week52Low":0.95,"pbRate":"1.35","psRate":"6.03","week52High":1.1,"institutionHeld":0,"latestPrice":1,"committee":0.930594,"eps":0,"divideRate":0,"volume":7662,"delay":0,"ttmEps":0,"open":1.05,"prevYearClose":1.05,"prevWeekClose":1.05,"prevMonthClose":1.05,"prevQuarterClose":1.05},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":23077988,"yearFounded":2005,"address":"7 Eden Park Drive,Level 5,Macquarie Park,New South Wales,Australia","zipCode":"2113","officePhone":"61 2 8935 9629"},"stockCompanyDetail":{"websiteUrl":"http://www.oncosil.com.au","stockEarnings":[{"period":"1week","weight":-0.0476},{"period":"ytd","weight":-0.0476}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0414},{"period":"3month","weight":0.0546},{"period":"6month","weight":0.1356},{"period":"1year","weight":0.1958},{"period":"ytd","weight":0.1466}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.","exchange":"ASX","name":"ONCOSIL MEDICAL LTD","nameEN":"ONCOSIL MEDICAL LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OSLDA.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSLDA.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-13","symbol":"OSLDA.AU","reason":null,"defaultRemindTime":1749772800000,"announcedDate":"2025-05-01","type":"delisting","dateTimestamp":1749736800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSLDA.AU\",market:\"AU\",,,undefined,":[]}}